The Stoxx Europe 600 index fell to an intraday low of 0.5%.Maiwell Technology rose more than 11% to a record high, and announced a breakthrough in customized high-bandwidth memory. Maiwell Technology rose more than 11% in intraday trading to US$ 121.86, with its share price reaching a record high and its market value exceeding US$ 100 billion. Maywell Technology announced on Wednesday that the company has made a breakthrough in customized high-bandwidth memory (HBM) for artificial intelligence processors. It is reported that the new artificial intelligence accelerator architecture (XPU) will increase computing power by 25%, memory by 33%, and improve energy efficiency. The company is cooperating with Micron Technology, Samsung and SK Hynix to customize HBM processors for accelerators.Jiaying Pharmaceutical Co., Ltd.: It plans to buy back 7 million to 13.5 million shares. Jiaying Pharmaceutical announced that it plans to use its own funds to buy back some issued RMB common shares (A shares) by centralized bidding for the implementation of employee stock ownership plan or equity incentive. The price of repurchased shares is not higher than 9.80 yuan/share (inclusive), and the number of shares to be repurchased is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; And no more than 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. The repurchase period is within 12 months from the date when the company's board of directors deliberated and approved the share repurchase plan.
Institution: The European Central Bank is paying attention to the weakness of the euro. The European Central Bank said yesterday that inflation is slowing down and hinted that it will cut interest rates again. However, Joost Van Leenders, an analyst at Van Lanschot kemen, said in a report that the European Central Bank will pay close attention to the recent weakness of the euro. As the import price rises, a weak currency may push up inflation. The senior investment strategist said that since the current deposit interest rate in the euro zone is 3% and the neutral interest rate is around 2%, the European Central Bank will cut interest rates at least four times. However, European Central Bank President Lagarde stressed that the inflation risk is two-sided.American natural gas futures fell more than 3.00% in the day and are now reported at $3.351/million British heat.The yield of German 10-year government bonds is the biggest weekly increase since mid-April. The yield of German 10-year government bonds hit the highest level since November 25th, at 2.233%.
Japanese people protested against sexual violence by US troops stationed in Japan. On the evening of 13th, Japanese people held a rally outside the Japanese Foreign Ministry in Tokyo to protest against sexual violence by US troops stationed in Japan. (Xinhua News Agency)Sources: Leaders of Germany, France, Poland, NATO and other countries will meet in Brussels on Wednesday to discuss Ukraine. Zelensky will also attend the Ukrainian meeting.Mckinsey agreed to pay $650 million to settle the criminal investigation of opioids by the U.S. Department of Justice. Mckinsey submitted a five-year deferred prosecution agreement to the federal court in Abingdon, Virginia, and agreed to pay $650 million to settle the criminal investigation of the U.S. Department of Justice on its work in guiding the opioid manufacturer Purdue Pharmaceutical to increase sales. According to court documents, Martin Elling, a former senior partner of McKinsey, agreed to plead guilty to obstruction of justice because he destroyed McKinsey's consulting records for Purdue Pharmaceutical. He will plead guilty on January 10th next year. Mckinsey has previously reached various settlement agreements totaling nearly $1 billion. The company had previously faced lawsuits in several States in the United States, and was accused of providing sales analysis and marketing advice to pharmaceutical companies such as Purdue Pharmaceutical and Johnson & Johnson, which contributed to the popularity of opioids.
Strategy guide
12-14
Strategy guide 12-14